Table 2.
FMK-UP |
OPH-UP |
FMK-DOWN |
OPH-DOWN |
||||
---|---|---|---|---|---|---|---|
Gene | Fold Change | Gene | Fold Change | Gene | Fold Change | Gene | Fold Change |
Ccl5 | 87.96 | Ccl5 | 51.90 | Tyrobp | −50.06 | Mrc1 | −10.53 |
Plac8 | 62.56 | Plac8 | 34.23 | Laptm5 | −37.85 | Adgre1 | −10.04 |
Cxcl10 | 43.30 | Cxcl10 | 32.77 | Adgre1 | −37.47 | Tyrobp | −8.47 |
Ifi44 | 34.85 | Ifi44 | 29.71 | Lcp1 | −34.18 | Trem2 | −8.08 |
Usp18 | 30.79 | Usp18 | 27.17 | Msr1 | −33.00 | Cyth4 | −7.27 |
Isg15 | 28.24 | Cxcl9 | 24.57 | Csf1r | −32.16 | Cd68 | −7.07 |
Irf7 | 27.35 | Gbp3 | 24.56 | Nckap1 | −26.79 | Slc37a2 | −7.03 |
Gbp3 | 25.68 | Ifit1 | 22.56 | Fyb | −24.34 | Mmp9 | −7.01 |
Ifit1 | 23.57 | Isg15 | 22.18 | Trem2 | −23.95 | Hpgds | −6.98 |
Ifih1 | 23.37 | Irf7 | 21.56 | Hpgds | −21.50 | Ms4a7 | −6.61 |
Mx1 | 21.92 | H2-Q4 | 20.57 | Ms4a7 | −21.48 | Slc7a8 | −6.50 |
Cxcl9 | 21.39 | Ifih1 | 19.64 | Ctss | −19.24 | Csf1r | −6.37 |
H2-Q4 | 19.70 | Mx1 | 18.25 | Clec4a2 | −18.09 | Fermt3 | −6.34 |
Oas1b | 19.63 | Oas1b | 18.21 | Spi1 | −16.90 | Fyb | −6.14 |
Rsad2 | 18.34 | Rsad2 | 17.16 | Ptpn6 | −16.71 | Fcgr2b | −6.12 |
Zbp1 | 17.19 | Oasl2 | 14.61 | C1qa | −16.46 | Vav1 | −6.12 |
Herc6 | 17.11 | Herc6 | 13.98 | Fermt3 | −15.18 | Lcp1 | −6.03 |
Gbp2 | 15.83 | Ecel1 | 13.11 | Myo1f | −14.72 | Pf4 | −5.96 |
Oasl2 | 15.60 | Gbp2 | 12.95 | Coro1a | −14.37 | Pik3cg | −5.94 |
Gbp9 | 15.01 | Tap1 | 12.34 | Igsf6 | −13.87 | Nckap1l | −5.79 |
FMK UP = genes upregulated after FMK inhibitor; FMK DOWN = genes downregulated after FMK inhibitor; OPH UP = genes upregulated after OPH inhibitor; OPH DOWN = genes downregulated after OPH inhibitor.
Bold—affected by both inhibitors (FMK and OPH) and being related to OA. Fold changes are included in the right columns. The complete list of upregulated and downregulated genes including fold changes is in Supplementary File 1.